pharmaceutical investing Novartis Advanced Accelerator Applications Receives FDA Approval for Lutathera
pharmaceutical investing Novartis completes tender offer for Advanced Accelerator Applications S.A. and commencement of subsequent offering period
Advanced Accelerator Applications Announces Pricing of $150 Million Public Offering of American Depositary Shares
ITEL signs agreement with Advanced Accelerator Applications to commercialize F-18 radiopharmaceuticals in Southern Italy
Alvopetro Announces Q3 2025 Financial Results and an Operational Update Including Record October Sales
Altech Batteries Ltd Service Data Confirms Exceptionally Low Failure Rate for Sodium-Nickel-Chloride Batteries
Allied Critical Metals Expands Santa Helena Breccia with 6.0 Metres of 1.02% WO3 Intercept at Borralha